Purchases and Sales Made in Q2 2023 in Adaptimmune Therapeutics PLC (ADAP)
This table provides information about the institutional ownership of Adaptimmune Therapeutics PLC (ADAP) during Q2 2023. The information is specifically focused on institutions that hold shares of Adaptimmune Therapeutics PLC.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 09, 2023
Q2 2023
|
Us Bancorp \De\
|
BUY
|
- |
1.06KNew |
$952 - $1.6K
|
1.06K
$677
|
|
|
Aug 10, 2023
Q2 2023
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
BUY
|
- |
1.06K+ 88.17% |
$952 - $1.6K
|
2.26K
$1.45K
|
|
|
Aug 14, 2023
Q2 2023
|
Captrust Financial Advisors
Raleigh, NC |
BUY
|
- |
302+ 1.4% |
$272 - $456
|
21.9K
$14K
|
|
|
Aug 14, 2023
Q2 2023
|
Investors Research Corp
|
BUY
|
- |
200New |
$180 - $302
|
200
$128
|
|
|
Aug 14, 2023
Q2 2023
|
Royal Bank Of Canada
Toronto, A6 |
BUY
|
- |
130+ 448.28% |
$117 - $196
|
159
$102
|
|
|
Jul 26, 2023
Q2 2023
|
Beaird Harris Wealth Management, LLC
Dallas, TX |
BUY
|
- |
92New |
$82.8 - $139
|
92
$58.9
|
|
|
Jul 19, 2023
Q2 2023
|
Salem Investment Counselors Inc
Winston Salem, NC |
BUY
|
- |
52New |
$46.8 - $78.5
|
52
$33.3
|
|
|
Aug 10, 2023
Q2 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Aug 11, 2023
Q2 2023
|
Nea Management Company, LLC
Timonium, MD |
SELL
|
- |
-1- -0.0% |
$0.9 - $1.51
|
17.1M
$10.9M
|
|
|
Aug 14, 2024
Q2 2023
|
Federation Des Caisses Desjardins Du Quebec
Levis, A8 |
SELL
|
- |
-30- 3.82% |
$27 - $45.3
|
755
$483
|
|
|
Jul 27, 2023
Q2 2023
|
China Universal Asset Management Co., Ltd.
Shanghai, F4 |
SELL
|
- |
-52- 2.64% |
$46.8 - $78.5
|
1.92K
$1.23K
|
|
|
May 21, 2024
Q2 2023
|
China Universal Asset Management Co., Ltd.
Shanghai, F4 |
SELL
|
- |
-52- 2.64% |
$46.8 - $78.5
|
1.92K
$1.23K
|
|
|
Jul 25, 2023
Q2 2023
|
Raymond James & Associates
St Petersburg, FL |
SELL
|
- |
-849- 7.51% |
$764 - $1.28K
|
10.4K
$6.69K
|
|
|
Aug 14, 2023
Q2 2023
|
Cubist Systematic Strategies, LLC
Stamford, CT |
SELL
|
- |
-2.52K- 20.04% |
$2.27K - $3.8K
|
10K
$6.43K
|
|
|
Aug 14, 2023
Q2 2023
|
Bayesian Capital Management, LP
Brooklyn, NY |
SELL
|
- |
-3.2K- 21.64% |
$2.88K - $4.83K
|
11.6K
$7.42K
|
|
|
Aug 04, 2023
Q2 2023
|
Simplex Trading, LLC
|
SELL
|
- |
-3.68K- 28.12% |
$3.31K - $5.56K
|
9.41K
$6.02K
|
|
|
Aug 14, 2023
Q2 2023
|
Gsa Capital Partners LLP
London, X0 |
SELL
|
- |
-14.3K- 29.46% |
$12.9K - $21.6K
|
34.3K
$22K
|
|
|
Aug 14, 2023
Q2 2023
|
Lazard Asset Management LLC
New York, NY |
SELL
|
- |
-15.1K- 78.4% |
$13.6K - $22.8K
|
4.17K
$2.67K
|
|
|
Aug 14, 2023
Q2 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-175K- 7.78% |
$158K - $265K
|
2.08M
$1.33M
|
|
|
Aug 14, 2023
Q2 2023
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-703K- 13.02% |
$633K - $1.06M
|
4.7M
$3.01M
|
|
|
Aug 14, 2023
Q2 2023
|
Endurant Capital Management LP
San Mateo, CA |
SELL
|
- |
-840K- 50.56% |
$756K - $1.27M
|
821K
$525K
|